Cargando…

Type I interferon, anti-interferon antibodies, and COVID-19

Detalles Bibliográficos
Autores principales:	Calabrese, Leonard H, Winthrop, Kevin, Strand, Vibeke, Yazdany, Jinoos, Walter, Jolan E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906736/ https://www.ncbi.nlm.nih.gov/pubmed/33655222 http://dx.doi.org/10.1016/S2665-9913(21)00034-5

Ejemplares similares

Dysregulation of type I interferon responses in COVID-19
por: Acharya, Dhiraj, et al.
Publicado: (2020)

The type I interferon response in COVID-19: implications for treatment
por: Lee, Jeong Seok, et al.
Publicado: (2020)

The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
por: Robinson, Philip C., et al.
Publicado: (2020)

Racial and ethnic differences in COVID-19 outcomes: a call to action
por: Robinson, Philip C, et al.
Publicado: (2022)

Interferon beta-1b for COVID-19
por: Shalhoub, Sarah
Publicado: (2020)

Nebulised interferon beta-1a for patients with COVID-19
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Subcutaneous interferon beta-1a in COVID-19: raking the ashes of an intervention trial
por: Wilkinson, Tom
Publicado: (2021)

Type I Interferons in COVID-19 Pathogenesis
por: Palermo, Enrico, et al.
Publicado: (2021)

COVID-19 diverse outcomes: Aggravated reinfection, type I interferons and antibodies
por: Costa Silva, Rafael Cardoso Maciel, et al.
Publicado: (2022)

Anti-inflammatory properties of Type I interferons
por: Billiau, Alfons
Publicado: (2006)

Role of interferon-induced GTPases in leishmaniasis
por: Lipoldová, Marie, et al.
Publicado: (2022)

Type I interferon
por: Niewold, Timothy B.
Publicado: (2020)

Roles of Type I and III Interferons in COVID-19
por: Choi, Hojun, et al.
Publicado: (2021)

Differential regulation of the interferon response in systemic lupus erythematosus distinguishes patients of Asian ancestry
por: Rector, Ian, et al.
Publicado: (2023)

Type I interferon shapes the quantity and quality of the anti‐Zika virus antibody response
por: Lee, Cheryl Yi‐Pin, et al.
Publicado: (2020)

Auto-anticorps anti-interférons de type I et COVID-19 sévère
por: Bastard, Paul, et al.
Publicado: (2021)

Anti-interferon-alpha autoantibodies in patients with inborn errors of Immunity and rheumatic diseases before and during the COVID-19 pandemic
por: Dasso, Joseph, et al.
Publicado: (2023)

Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies
por: Akbil, Bengisu, et al.
Publicado: (2022)

The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19
por: Schreiber, Gideon
Publicado: (2020)

Type-I interferons in atherosclerosis
por: Chen, Hung-Jen, et al.
Publicado: (2019)

Long COVID: defining the role of rheumatology in care and research
por: Calabrese, Leonard H, et al.
Publicado: (2022)

Type I and II Interferons in the Anti-Tumor Immune Response
por: Fenton, Sarah E., et al.
Publicado: (2021)

Long COVID in inflammatory rheumatic diseases—what's in a name?
por: Calabrese, Leonard H
Publicado: (2023)

Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance
por: Pervolaraki, Kalliopi, et al.
Publicado: (2018)

Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients
por: Goncalves, David, et al.
Publicado: (2021)

High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19
por: Scordio, Mirko, et al.
Publicado: (2022)

Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review
por: Tonutti, Antonio, et al.
Publicado: (2022)

Anti-Interferon Auto-Antibodies in Autoimmune Polyendocrinopathy Syndrome Type 1
por: Levin, Michael
Publicado: (2006)

Reply to Jakovac: COVID-19, vitamin D, and type I interferon
por: Gauzzi, Maria Cristina, et al.
Publicado: (2020)

Type I interferon: From innate response to treatment for COVID‐19
por: Lin, Fuyu, et al.
Publicado: (2020)

Rheumatology and COVID-19 at 1 year: facing the unknowns
por: Calabrese, Leonard, et al.
Publicado: (2021)

Effect of Type-I Interferon on Retroviruses
por: Gómez-Lucía, Esperanza, et al.
Publicado: (2009)

Bunyaviruses and the Type I Interferon System
por: Elliott, Richard M., et al.
Publicado: (2009)

Overview of the biology of type I interferons
por: Kalliolias, George D, et al.
Publicado: (2010)

Type I interferon: friend or foe?
por: Trinchieri, Giorgio
Publicado: (2010)

Type I Interferon in Human Autoimmunity
por: Niewold, Timothy B.
Publicado: (2014)

Phleboviruses and the Type I Interferon Response
por: Wuerth, Jennifer Deborah, et al.
Publicado: (2016)

The Protective Role of Type I Interferons in the Gastrointestinal Tract
por: Kotredes, Kevin P., et al.
Publicado: (2017)

Type I and type III interferon in opposition?
por: Park, Matthew D.
Publicado: (2020)

The bacterial pathogen Listeria monocytogenes and the interferon family: type I, type II and type III interferons
por: Dussurget, Olivier, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8pnpv4epustma2q3p6emnfq0bn